These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30853360)

  • 1. Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.
    Felip I; Moiola CP; Megino-Luque C; Lopez-Gil C; Cabrera S; Solé-Sánchez S; Muñoz-Guardiola P; Megias-Roda E; Pérez-Montoyo H; Alfon J; Yeste-Velasco M; Santacana M; Dolcet X; Reques A; Oaknin A; Rodríguez-Freixinos V; Lizcano JM; Domènech C; Gil-Moreno A; Matias-Guiu X; Colas E; Eritja N
    Gynecol Oncol; 2019 May; 153(2):425-435. PubMed ID: 30853360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer.
    López-Plana A; Fernández-Nogueira P; Muñoz-Guardiola P; Solé-Sánchez S; Megías-Roda E; Pérez-Montoyo H; Jauregui P; Yeste-Velasco M; Gómez-Ferreria M; Erazo T; Ametller E; Recalde-Percaz L; Moragas-Garcia N; Noguera-Castells A; Mancino M; Morán T; Nadal E; Alfón J; Domènech C; Gascon P; Lizcano JM; Fuster G; Bragado P
    Int J Cancer; 2020 Aug; 147(4):1163-1179. PubMed ID: 31943158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase.
    Erazo T; Lorente M; López-Plana A; Muñoz-Guardiola P; Fernández-Nogueira P; García-Martínez JA; Bragado P; Fuster G; Salazar M; Espadaler J; Hernández-Losa J; Bayascas JR; Cortal M; Vidal L; Gascón P; Gómez-Ferreria M; Alfón J; Velasco G; Domènech C; Lizcano JM
    Clin Cancer Res; 2016 May; 22(10):2508-19. PubMed ID: 26671995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells.
    Muñoz-Guardiola P; Casas J; Megías-Roda E; Solé S; Perez-Montoyo H; Yeste-Velasco M; Erazo T; Diéguez-Martínez N; Espinosa-Gil S; Muñoz-Pinedo C; Yoldi G; Abad JL; Segura MF; Moran T; Romeo M; Bosch-Barrera J; Oaknin A; Alfón J; Domènech C; Fabriàs G; Velasco G; Lizcano JM
    Autophagy; 2021 Jun; 17(6):1349-1366. PubMed ID: 32397857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer.
    Leary A; Estévez-García P; Sabatier R; Ray-Coquard I; Romeo M; Barretina-Ginesta P; Gil-Martin M; Garralda E; Bosch-Barrera J; Morán T; Martin-Martorell P; Nadal E; Gascón P; Rodon J; Lizcano JM; Muñoz-Guardiola P; Fierro-Durán G; Pedrós-Gámez O; Pérez-Montoyo H; Yeste-Velasco M; Cortal M; Pérez-Campos A; Alfon J; Domenech C; Pérez-Fidalgo A; Oaknin A
    BMC Cancer; 2024 Jul; 24(1):876. PubMed ID: 39039449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer.
    Mondal D; Mathur A; Chandra PK
    Biochimie; 2016 May; 124():34-52. PubMed ID: 26855171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models.
    Mancini A; Colapietro A; Cristiano L; Rossetti A; Mattei V; Gravina GL; Perez-Montoyo H; Yeste-Velasco M; Alfon J; Domenech C; Festuccia C
    Front Oncol; 2022; 12():943064. PubMed ID: 36408162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
    Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
    J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.
    Li K; Zhang TT; Wang F; Cui B; Zhao CX; Yu JJ; Lv XX; Zhang XW; Yang ZN; Huang B; Li X; Hua F; Hu ZW
    Oncogene; 2018 May; 37(22):2967-2981. PubMed ID: 29520103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway.
    Su J; Yan Y; Qu J; Xue X; Liu Z; Cai H
    Oncol Rep; 2017 Mar; 37(3):1565-1572. PubMed ID: 28184934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIB3 inhibits proliferation and promotes osteogenesis in hBMSCs by regulating the ERK1/2 signaling pathway.
    Zhang C; Hong FF; Wang CC; Li L; Chen JL; Liu F; Quan RF; Wang JF
    Sci Rep; 2017 Sep; 7(1):10342. PubMed ID: 28871113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
    Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW
    Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIB3 facilitates glioblastoma progression via restraining autophagy.
    Tang Z; Chen H; Zhong D; Wei W; Liu L; Duan Q; Han B; Li G
    Aging (Albany NY); 2020 Nov; 12(24):25020-25034. PubMed ID: 33203798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.
    Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K
    Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antitumour drug ABTL0812 impairs neuroblastoma growth through endoplasmic reticulum stress-mediated autophagy and apoptosis.
    París-Coderch L; Soriano A; Jiménez C; Erazo T; Muñoz-Guardiola P; Masanas M; Antonelli R; Boloix A; Alfón J; Pérez-Montoyo H; Yeste-Velasco M; Domènech C; Roma J; Sánchez de Toledo J; Moreno L; Lizcano JM; Gallego S; Segura MF
    Cell Death Dis; 2020 Sep; 11(9):773. PubMed ID: 32943619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapalog-Mediated Repression of Tribbles Pseudokinase 3 Regulates Pre-mRNA Splicing.
    Stefanovska B; Vicier CE; Dayris T; Ogryzko V; Scott V; Bouakka I; Delaloge S; Rocca A; Le Saux O; Trédan O; Bachelot T; André F; Fromigué O
    Cancer Res; 2020 Jun; 80(11):2190-2203. PubMed ID: 32245792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway.
    Bao XY; Sun M; Peng TT; Han DM
    Cancer Biomark; 2021; 31(4):307-315. PubMed ID: 33896816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivity.
    Wennemers M; Bussink J; Grebenchtchikov N; Sweep FC; Span PN
    Radiother Oncol; 2011 Oct; 101(1):198-202. PubMed ID: 21704407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIB3 enhances cell viability during glucose deprivation in HEK293-derived cells by upregulating IGFBP2, a novel nutrient deficiency survival factor.
    Örd T; Örd D; Adler P; Vilo J; Örd T
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2492-505. PubMed ID: 26094770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of TRIB3 mRNA and protein in breast cancer.
    Wennemers M; Bussink J; van den Beucken T; Sweep FC; Span PN
    PLoS One; 2012; 7(11):e49439. PubMed ID: 23185332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.